Sus aplicaciones clínicas | 14 OCT 18

Empleo de probióticos en pediatría

Importancia de la modulación de la microbiota intestinal mediante los alimentos funcionales
6
9
Fuente: Sección de Gastroenterología y Nutrición Pediátrica. Hospital General Universitario Gregorio Marañón. Madrid. España Aplicaciones clínicas del empleo de probióticos en pediatría
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1. Suarez JE. Microbiota autóctona, probióticos y prebióticos. Nutr Hosp 2013; 28 (Suppl. 1): s38-s41.

2. Johnson CL, Versalovic J. The human microbiome and its potential importance to pediatrics. Pediatrics 2012; 129: 950-60.

3. Ringel-Kulka T. Targeting the intestinal microbiota in the pediatric population: a clinical perspective. Nutr Clin Pract 2012;27: 226-34.

4. Thomas DW, Creer FR and Comité on Nutrition. Probiotics and prebiotics in Pediatrics. Pediatrics 2010; 126: 1217-31.

5. Floch MH, Walker WA, Madsen K, Sanders ME, Macfarlane GT, Flint HJ et al. Recommendations for probiotic use-2011 update. J Clin Gastroenterol 2011; 45: S 168-71.

6. WGO. Probióticos y prebióticos. En: Guías Mundiales de la Organización Mundial de Gastroenterología. Octubre 2011. www.Worldgastroenterology.org/probiotics-prebiotics.html.

7. Ciorba MA. A gastroenterologist’s guide to probiotics. Clin Gastroenterol Hepatol 2012; 10: 960-8.

8. Pies´cik-Lech M, Shamir R, Guarino A, Szajewska H. Review Article: The Management of Acute Gastroenteritis in Children. Aliment Pharmacol Ther 2013; 37: 289-303.

9. Guarino A, AMlbano F, Ashkenazi S, et al. European Society for Paediatric Gatroenterology, Hepatology and Nutrition/ European Society for Paediatric Infectious Diseases Guidelines for the Management of Acute Gastroenteritis in Children in Europe. J Pediatr Gastroentrol Nutr 2008; 46 (Suppl. 2): s81-s122.

10. Cincinnati Children s Hospital Medical Center. Evidence based clinical practice guideline for children with acute gastroenteritis (AGE). Cincinnati (OH) 2005: Guideline 5; pp. 1-15.

11. Khanna R, Lakhanpaul M, Burman-Roy S, Murphy MS. Diarrhoea and vomiting caused by gastroenteritis in children under 5 years: summary of NICE guidance. BMJ 2009; 338: b1350. doi: 10.1136/bmj.b1350.

12. Guandalini S. Probiotics for Children With diarrhea. An Update. J Clin Gastroenterol 2008; 42: 53-7.

13. Allen SJ, Martínez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; (11): CD003048.

14. Szajewska, H, Skorka, A, Dylag, M. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007; 25: 257-64.

15. Szajewska, H, Skorka, A, Ruszczynski, M, Gieruszczak-Bialek, D. Meta-analysis: Lactobacillus GG for reating acute diarrhoea in children. Aliment Pharmacol Ther 2007; 25: 871-81.

16. Dubey AP, Rajeshwari K, Chakrsvarty A, Famularo G. Use of VSL#3 in the treatment of rotavirus diarrhea in children: preliminary results. J Clin Gastroenterol 2008; 42: 126-9.

17. Alam S, Mushtaq M. Antibiotic-associated diarrhea in children. Indian Pediatr 2009; 46: 491-6. Review.

18. Szajewska H, Wanke, M Patro B. Meta-analysis: the effects of Lactobacillus rhamnosus GG supplementation for the prevention of healthcare-associated diarrhoea in children. Aliment Pharmacol Ther 2011; 34: 1079-87.

19. Szajewska H, Ruszczynski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006; 149: 367-72.

20. Johnston B, Goldenberg J, Vandvik P, Sun X, Guyatt G. Probióticos para la prevención de la diarrea asociada con antibióticos en niños. Cochrane Database of Systematic Reviews 2011 Issue 11. Art. No.: CD004827. DOI: 10.1002/14651858.CD004827.

21. Novak J, Katz JA. Probiotics and prebiotics for gastrointestinal infections. Curr Infect Dis Rep 2006; 8: 103-9.

22. Kachrimanidou M, Malisiovas N. Clostridium difficile infection: a comprehensive review. Crit Rev Microbiol 2011; 37:178-87.

23. Hickson M. Probiotics in the prevention antibiotic-associated diarrhoea and Clostridium difficile. Therap Adv Gastroenterol 2011; 4: 185-97.

24. Lynne V McFarland. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol2010; 16: 2202-22.

25. Surawicz CHM. The Search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii. Clinical Infectious Diseases 2000; 31: 1012-7.

26. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhoea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101: 812-22.

27. Wult M. Activity of 3 desinfectants and acidified nitrite against Clostridium difficile spores. Infect Control Hosp Epidemiol 2003; 24: 765-8.

28. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512-9.

29. Angulo S, Sans M. Microbiota intestinal y enfermedad inflamatoria intestinal. Enf Inf Intestinal al día 2008; 7: 5-9.

30. Guarner F. Microbiota intestinal y enfermedades inflamatorias del intestino. Gastroenterol Hepatol 2011; 34: 147-154.

31. Burruel N. Probioticos en la enfermedad inflamatoria intestinal. Enf Inf Intestinal al día 2008; 7: 23-30.

32. Cain AM, Karpa KD. Clinical utility of probiotics in inflammatory bowel disease. Altern Ther Health Med 2011; 17: 72-9. Review.

33. Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009; 104: 437-43.

34. Oliva S Di Nardo G, Ferrari F, Mallardo S, Rossi P, Patrizi G et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther 2012; 35: 327-34.

35. Guandalini S. Update on the role of probiotics in the therapy of pediatric inflammatory bowel disease. Expert Rev Clin Immunol 2010; 6: 47-54. Review.

36. Meijer BJ, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J Clin Gastroenterol2011; 45 (Suppl): S139-44.572

37. Sartor RB. Probiotics for gastrointestinal diseases. www.uptodate.com 2013.

38. Verna CE, Lucak S. Use of probiotics in GI disorders: What to recommend? Therapeutic Advances in Gastroenterology 2010;3: 307-319.

39. Hoveyda N, Heneghan C, Mahtani KR, Perera R, Roberts N,Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol 2009; 9: 15.

40. McFarland LV, Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol2008; 14: 2650-61.

41. Guandalini S, Magazzù G, Cucchiara S, Gopalan S, Romano C, Canani RB et al. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicentre, randomized, placebocontrolled, double-blinded, cross-over study. JPGN 2010; 51: 24-30. doi: 10.1097/MPG.0b013e3181ca4d95.

42. Quigley EMM, Quera R. Small intestinal bacteria overgrowth: roles of antibiotics, prebiotics and probiotics. Gastrenterology 2006; 130: S78-90.

43. Vanderhoof JA, Sheng M, Wei C. Probiotics and Intestinal Inflammatory. Dis Inf Child 2000; 30: 34-8.

44. Bausserman M, MichailS. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatric 2005; 147: 197-201.

45. Gawro ska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment PharmacolTher 2007; 25: 177-84.

46. Francavilla R. A Randomized Controlled Trial of Lactobacillus GG in children with functional abdominal pain. J Pediatr 2011; 159: 165-6.

47. Bu LN, Chang MH, Ni YH, Chen HL, Cheng CC. Lactobacillus casei rhamnosus Lcr35 in children with chronic constipation. Pediatr Int 2007; 49: 485-90.

48. Tabbers MM, Chmielewska A, Roseboom MG, et al. Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomized controlled trial (NTRTC: 1571). BMC Pediatrics 2009; 9: 22.

49. Bekkali N, Bongers M, Van den Berg M et al. The role of a probiotics mixture in the treatment of childhood constipation: a pilot study. Nutrition Journal 2007; 6: 17.

50. Tabbers MM, de Milliano I, Roseboom MG, Benninga MA. Is Bifidobacterium breve effective in the treatment of childhood constipation? Results from a pilot study. Nutrition Journal 2011; 10: 19.

51. Moore N, Chao C, Yang L et al. Effects of fructo-ologosaccharide- supplemented cereal: a double blind placebo controlled multinational study. Br J Nutr 2003; 90: 581-7.

52. Savino F, Cordisco L. Lactobacillus reuteri DSM Infantile Colic: A Randomized, Double- Blind Placebo-Controlled Trial. Pediatrics 2010; 126; e526; originally published online August 16, 2010.

53. Savino F, Pelle E, Palumeri E, Oggero R, Miniero R. Lactobacillus reuteri (American type culture collection strain 55 730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 2007; 119.

54. Szajewska H, Gyrczuk E, Horvath A. Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: a randomized, double-blind, placebo-controlled trial. J Pediat 2013; 162: 257-62.

55. Lesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr 2007; 137: S812-8.

56. Sykora J. Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children. A prospective randomized double-blind study. J Clin Gastroenterol 2005; 39: 692-8.

57. Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Alim Pharm Ther 2007; 25: 155-68.

58. Szajewska H, Horvath A, Pivowarzyk A. Meta-analysis: the effect of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and t side effects during treatment. Alim Pharm Ther 2010; 32: 1069-79.

59. Szajewska H, Albrecht P, Topczewska-Cabanek A. Randomized, double-blind, Placebo-controlled trial: effect of Lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. JPGN 2008; 48: 431-6.

60. Lionetti E et al. Lactobacillus reuteri therapy to reduce sideeffects during anti -Helicobacter pylori treatment in children: a randomized placebo controlled trial. Aliment Pharmacol Ther, 2006; 24 (10): 1461-8.

61. Deshpande GC, Rao SC, Keil AD, Patole SK. Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med 2011; 9: 92.

62. Desphande GC, Rao SC, Patole SK, Bulsara M. Updated metaanalysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010; 125: 921-30.

63. Al-Hosni M, Duenas M, Hawk M, Stewart LA et al. Probiotics supplemented feeding in extremely low-birth-weigth infants. J Perinatol 2012; 32 (4): 253-9.

64. Chou IC, Kuo HT, Chang JS et al. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. J Pediatr 2010; 156 (3): 393-6.

65. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T.Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011; (3): CD005496.

66. Heyman MB. Lactose Intolerance in Infants, Children and Adolescents. Pediatrics 2006; 118: 1279-86.

67. Levri KM et al. Do probiotics reduce adult lactose intolerance? A systematic review. The Journal of Family Practice 2005; 54:613-20.

68. Lindfords, T. Blomqvist, K. Juuti-Uusitalo K, Stenman S, Venäläinen J, Mäki M, Kaukinen K. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Imnmunol 2008; 152:552-8.

69. Rizzello C, De Angelis M, Di Cagno R et al. Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease. Appl Environ Microbiol 2007; 73: 4499-507.

70. Di Cagno R, De Angelis M, Auricchio S, Greco L, Clarke C, De Vincenzi M et al. Sourdough Bread Made from Wheat and Nontoxic Flours and Started with Selected Lactobacilli Is Tole -rated in Celiac Sprue Patients. Appl Environ Microbiol 2004; 70: 1088-96.

71. Gobbetti M, Rizzello CG, Di Cagno R, De Angelis M. Sourdough lactobacilli and celiac disease. Food Microbiology 2007; 24: 187-96.

72. Sánchez E, Donat E, Ribes-Konicks C, Calabuig M, Sanz Y. Intestinal Bacteroides species associated with coeliac disease. J Clin Pathol 2010; 63: 1105-11.

73. Kalliomaki M, Collado MC, Salminem S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008; 87: 534-8.

74. Collado MC. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 2008; 88 (4): 894-9.

75. Delzenne NM, Neyrinck AM, Backhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol 2011. Doi: 10.1038.

76. Rodríguez JM, Sobrino OJ, Marcos A, Collado MC, Pérez G, Martinez MC et al. ¿Existe una relación entre la microbiota intestinal, el consumo de probióticos y la modulación del peso corporal? Nutr Hosp 2013; 28 (Suppl. 1): s3-s12.

77. Kaur A. A pilot study on the effects of curd (dahi) & leaf protein concentrate in children with protein energy malnutrition (PEM). Indian J Med Res 2007; 199-203.

78. Kerac M. Probiotics and prebiotics for severe acute malnutrition (PRONUT study): a double-blind efficacy randomised controlled trial in Malawi. Lancet 2009; 374: 136-44.

79. Maldonado C, Novotny I, Moreno A, Carruega E, Weill R, Perdigon G. Impact of a probiotic fermented milk in the gut ecosystem and in the systemic immunity using a non-severe protein-energy-malnutrition model in mice. BMC Gastroenterology 2011; 11: 64.

80. Solis B, Samartin S, Gomez S, Nova E, Marcos A. Probiotics as a help in children suffering from malnutrition and diarrhoea., and cols. European J Clin Nutr 2002; 56 (Suppl. 3):S57-S59.

81. Bruzzese E, Raia V, Spagnuolo MI, Volpicelli M, De Marco G, Maiuri L, Guarino A. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004; 20: 813-9.

82. Bruzzese E, Raia V, Spagnuolo MI, Volpicelli M, De Marco G, Maiuri L, Guarino A. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin Nutr 2007; 26: 322-8.

83. Doron S, Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Rev Anti Infect Ther 2006; 4: 261-75.

84. Infante D, Redecillas S, Torrent A, Segarra O, Maldonado M, Gartner L et al. Optimización de la función intestinal en pacientes con fibrosis quística mediante la administración de probióticos. An Pediatr (Barc) 2008; 69: 501-5.

85. Weiss B, Bujanover Y, Yahav Y, Vilozni D, Fireman E, Efrati O. et al. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatr Pulmonol 2010; 45: 536-40.

86. Kanamori Y, Sugiyama M. Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J Pediatr Surg 2004; 39: 1686-92.

87. Sentongo TA, Cohran V. Intestinal Permeability and Effects of Lactobacillus rhamnosus Therapy in Children with Short Bowel Syndrome. J Pediatr Gastroenterol Nutr 2008; 46:41-7.

88. Uchida Kl. Inmunonutricional effects during symbiotics therapy in pediatric patients with short bowel syndrome. Pediatric Surg Int 2007; 23: 243-8.

89. Osborn DA, Sinn JKH. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006475.

90. Canani RB, Nocerino R, Terrin G, Coruzzo A, Cosenza L, Leona L et al. Effect of Lactobacillus GG on tolerante asquisition in infants with cow s milk allergy: a randomized trial. J Allergy Clin Immunol 2012; 129: 580-2.

91. JM Moreno Villares .Actualizacion en Formulas infantiles. An Pediatric Contin 2011; 9: 31-40.

92. Supplementation of Infant Formula With Probiotics and/or Prebiotics: A Systematic Review and Comment by the ESPGHAN Committee on Nutrition. JPGN 2011; 52: 238-50.

93. Global Standard for the Composition of Infant Formula: Recommendations of an ESPGHAN Coordinated International Expert Group. JPGN 2005 41: 584-99.

94. Isolauri E, Salminen S; Probiotics: Use in Allergic Disorders: A Nutrition, Allergy, Mucosal Immunology and Intestinal Microbiota (NAMI) Research Group Report. J Clin Gastroenterol2008; 42: S91-S96.

95. Ozdemir O. Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin Experim Immunol 2010; 160: 295-304.

96. Hojsak I, Abdovi S, Szajewska H, Milosevi M, Krznari Z, Kolacek S. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 2010; 125: 1171-7.

97. Hao Q, Lu Z, Dong BR, Huang CQ, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2011; (9): CD006895.

98. Álvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: a modern perspective on a traditional the -rapy. Clin Infect Dis 2001; 32: 1567-76.99. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 2009; 124: 172-9.574.

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2020